← FDA DRUG APPROVALS

FDA ANDA · ANDA040192

PREDNISOLONE

Sponsor: WE PHARMS

APPLICATION
ANDA040192
TYPE
ANDA
ORIGINAL APPROVAL
1998-05-28
LATEST ACTION
2002-09-16
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

PREDNISOLONEDiscontinued
PREDNISOLONE 15MG/5ML · SOLUTION · ORAL

Approval history

2002-09-16Labeling · Supplement 8AP
2002-04-12Manufacturing (CMC) · Supplement 7AP
2000-08-28Manufacturing (CMC) · Supplement 2AP
2000-08-28Manufacturing (CMC) · Supplement 3AP
1998-07-16Labeling · Supplement 1AP
1998-05-28OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →